Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation
Global Economic Impact of COVID-19 Vaccines in the First Year: Evidence from PLOS Medicine The rapid development and deployment of COVID-19 vaccines were a pivotal part of the global response to the pandemic. A recent study published in PLOS Medicine evaluates the economic return-on-investment (ROI) of COVID-19 vaccination during the initial year…
Characteristics of and Clinical Criteria for Oropouche Virus Disease, United States, May 2024–January 2025
Characteristics and Clinical Criteria for Oropouche Virus Disease: Evidence Dossier The Oropouche virus (OROV) outbreak emerging in the Americas during 2024–2025 has prompted in-depth investigation by public health authorities. This dossier summarizes key evidence from a study published in the Emerging Infectious Diseases Journal (November 2026), analyzing clinical features and diagnostic criteria…
From preparedness to response: EU Reference Laboratories for Public Health in action
What is established The European Centre for Disease Prevention and Control (ECDC) highlights the crucial role of strong laboratory infrastructure in Europe’s preparedness and response to communicable disease threats. EU Reference Laboratories for Public Health (EURL-PH) have been set up to coordinate expertise and support national public health laboratories by harmonizing diagnostics,…
A guide to EU Reference Laboratories for Public Health
What is established In November 2026, the European Centre for Disease Prevention and Control (ECDC) published a comprehensive guide on the newly established EU Reference Laboratories for Public Health (EURLs). These laboratories form an integral part of the continent’s infrastructure for monitoring and responding to communicable disease threats. Their core purpose is…
A metabolomic signature of weight-loss and its associations with BMI-linked diseases: A post-hoc analysis of two intervention trials and a mendelian randomisation study
What is established Obesity is widely recognized as a major risk factor for various serious health conditions including heart failure, osteoarthritis, and certain cancers, notably kidney cancer. While the epidemiological links between excess body weight and these diseases are well documented, the specific molecular pathways that mediate these risks remain incompletely understood.…
Aage Bøttger Sørensen, 59
Evidence Dossier: Aage Bøttger Sørensen and His Contributions to Sociology of Inequality What is established Aage Bøttger Sørensen (1941–2001) was a notable sociologist whose scholarship focused on social inequality, particularly how structural and organizational factors shape socioeconomic standing and educational achievement. He completed his doctoral studies under James S. Coleman at Johns…
Indirect Healthcare-Associated Canine Sporotrichosis Caused by Sporothrix brasiliensis, Argentina, 2024
What is established Sporothrix brasiliensis is a fungal pathogen known to cause zoonotic sporotrichosis, primarily transmitted through bites, scratches, or exudates from infected domestic cats. Since the late 1990s, this species has emerged in Brazil and subsequently spread across South America. Domestic cats (Felis catus) serve as the main reservoir, while the…
Resorbable filling and reconstruction devices – Notified Body 2797 – 08/05/2026 – Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)
What is established On November 4, 2026, the European Medicines Agency (EMA) published an expert opinion related to resorbable filling and reconstruction devices. These devices are intended for medical use in tissue repair and restoration, gradually dissolving within the body after implantation. The document originates from the Clinical Evaluation Consultation Procedure (CECP),…
Ophthalmic devices ‐ other – Notified Body 0123 – 12/01/2025 – Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)
Ophthalmic Devices Clinical Evaluation: Expert Opinion from EMA Document This evidence dossier examines the expert opinion provided in a recent European Medicines Agency (EMA) document concerning ophthalmic devices subject to the Clinical Evaluation Consultation Procedure (CECP). The document reflects regulatory scrutiny and assessments relevant to device safety and performance in eye care…
Veterinary medicines European public assessment report (EPAR): Eravac, rabbit haemorrhagic disease vaccine (inactivated), Status: Withdrawn
Health & Science Evidence Dossier: Withdrawal of Eravac Rabbit Haemorrhagic Disease Vaccine What is established Eravac was a veterinary vaccine authorised within the European Union for protection against rabbit haemorrhagic disease virus type 2 (RHDV2). It was an inactivated viral vaccine developed to prevent a highly contagious and fatal disease in rabbits…